TrialAntimicrobial agents and chemotherapy2016

Preclinical and Clinical Resistance Profile of EDP-239, a Novel Hepatitis C Virus NS5A Inhibitor.

Christopher M Owens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.